Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aligos Therapeutics Inc
Swot
Aligos Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aligos Therapeutics Inc has 10 Strengths, 12 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(12)
Opportunity
(2)
Threats
(1)
Others
(0)
Companies with 10% increase in share price over three months, with rising net profit growth
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Biggest Price Losers from Open
High volume, top losers
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Declining Revenue every quarter for the past 2 quarters
Top Losers
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
